The Ruffer LLP Has $1,127,000 Position in Vascular Solutions, Inc. (VASC), Report finds

The Ruffer LLP Has $1,127,000 Position in Vascular Solutions, Inc. (VASC), Report finds

Several other large investors have also modified their holdings of VASC. BlackRock Fund Advisors increased its position in shares of Vascular Solutions by 5.2% in the third quarter. BlackRock Fund Advisors now owns 1,298,126 shares of the medical device company’s stock valued at $62,609,000 after buying an additional 64,592 shares in the last quarter. Neuberger Berman Group LLC increased its position in Vascular Solutions by 11.0% in the third quarter. Neuberger Berman Group LLC now owns 921,850 shares of the medical device company’s stock valued at $44,461,000 after buying an additional 91,300 shares during the period. PNC Financial Services Group Inc. increased its position in Vascular Solutions by 360,144.2% in the third quarter. PNC Financial Services Group Inc. now owns 432,293 shares of the medical device company’s stock valued at $20,849,000 after buying an additional 432,173 shares during the period. State Street Corp increased its position in Vascular Solutions by 11.5% in the fourth quarter. State Street Corp now owns 403,189 shares of the medical device company’s stock valued at $22,616,000 after buying an additional 41,674 shares during the period. Finally, Eagle Asset Management Inc. increased its position in Vascular Solutions by 19.1% in the third quarter. Eagle Asset Management Inc. now owns 294,106 shares of the medical device company’s stock valued at $14,184,000 after buying an additional 47,206 shares during the period. 81.61% of the stock is owned by hedge funds and other institutional investors.

Ruffer LLP continued to hold its stake in shares of Vascular Solutions, Inc. (NASDAQ:VASC) during the fourth quarter, Holdings Channel reports. The fund owned 20,000 shares of the medical device company’s stock at the end of the fourth quarter. Ruffer LLP owned approximately 0.11% of Vascular Solutions worth $1,127,000 as of its most recent SEC filing.

Shares of Vascular Solutions, Inc. (NASDAQ:VASC) remained flat at $56.00 during midday trading on Thursday. 138,024 shares of the company were exchanged. Vascular Solutions, Inc. has a 12 month low of $24.34 and a 12 month high of $57.15. The company has a 50-day moving average price of $55.85 and a 200-day moving average price of $50.74. The firm has a market capitalization of $981.85 million, a PE ratio of 81.40 and a beta of 0.98.

Several analysts have recently issued reports on the stock. Zacks Investment Research cut shares of Vascular Solutions from a “buy” rating to a “hold” rating in a research report on Wednesday, December 28th. Piper Jaffray Companies lowered shares of Vascular Solutions from an “overweight” rating to a “neutral” rating in a research report on Monday, December 5th. Canaccord Genuity lowered shares of Vascular Solutions from a “buy” rating to a “hold” rating in a research report on Monday, December 5th. Feltl & Co. downgraded shares of Vascular Solutions from a “buy” rating to a “hold” rating in a research note on Friday, December 2nd. Finally, Needham & Company LLC downgraded shares of Vascular Solutions from a “buy” rating to a “hold” rating in a research note on Friday, December 2nd. Six equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $51.80.

In related news, VP Chad Kugler sold 1,849 shares of the stock in a transaction on Thursday, December 22nd. The shares were sold at an average price of $55.70, for a total transaction of $102,989.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 6.90% of the stock is owned by corporate insiders.

Vascular Solutions Company Profile

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Want to see what other hedge funds are holding VASC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vascular Solutions, Inc. (NASDAQ:VASC).

Related posts

Leave a Comment